Juzenkai Medical Association
- Company typePrivate
- Founded1932
- HeadquartersOkayama, Japan
- Headcount1–10
- GTM typeB2C
- OfferingServices
Juzenkai Medical Association firmographics
Firmographics- Name
- Juzenkai Medical Association
- Legal name
- The Sakakibara Heart Institute of Okayama (心臓病センター榊原病院)
- Website
- https://sakakibara-hp.com
- Company type
- Private
- Founded year
- 1932
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Juzenkai Medical Association industry classification
Industry- Product category
- Cardiovascular Specialty Hospital Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)
- SIC
- Services-Hospitals (8060)
- akta.pro primary industry
- Cardiac & Cardiothoracic Specialty Hospitals (HLAFAHAA)
- akta.pro secondary industries
- Interventional Cardiology (PCI/Structural Heart) (HLAKABAB), Heart Failure & Transplant Cardiology (HLAKABAD), Cardiovascular / Cath Lab & Electrophysiology Centers (HLAFAIAI)
Keywords
Where Juzenkai Medical Association is headquartered
LocationHeadquarters
- HQ city
- Okayama
- HQ country
- Japan
- HQ region
- Asia
Offices1 record
Markets served
Juzenkai Medical Association business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others
Revenue model
- Public Health Insurance Medical Services: Core revenue from diagnosis, treatment, surgery, catheter procedures, hospitalization, and rehabilitation covered under Japan's universal public health insurance system. Services span cardiac surgery, catheter interventions, arrhythmia treatment, vascular surgery, and general medicine across 15 departments.
- Premium Health Checkup Services (Self-Pay): Premium cardiac and brain checkup (プレミアム心臓・脳ドック) offered as out-of-pocket self-pay service for health screening and early disease detection.
Go-to-market motion1 record
Distribution channels5 records
Marketing channels5 records
Juzenkai Medical Association product offering
Product offeringCore offering
Juzenkai Medical Association operates the Sakakibara Heart Institute of Okayama (心臓病センター榊原病院), a cardiovascular specialty hospital established in 1932. It delivers comprehensive cardiac care including open-heart and minimally invasive cardiac surgery (MICS, CABG, aortic surgery, VAD), catheter-based interventions (TAVI, MitraClip/M-TEER, TriClip/T-TEER, PCI, catheter ablation), cardiac device implantation (pacemaker, ICD, CRT/CRTD, leadless pacemaker), peripheral vascular stenting, advanced diagnostic imaging (320-row CT, RI scintigraphy, cardiac catheterization), cardiac rehabilitation, and a self-pay preventive Premium Heart and Brain Dock.
Product overview
Juzenkai Medical Association operates primarily through its flagship facility, the Sakakibara Heart Center (心臓病センター榊原病院), a cardiovascular specialty hospital established in 1932 in Okayama, Japan. The organization offers a comprehensive, integrated portfolio of cardiovascular diagnostic and therapeutic services organized across surgical treatments (MICS, CABG, aortic surgery, VAD), catheter-based treatments (TAVI, MitraClip/M-TEER, TriClip/T-TEER, PCI, stent placement, catheter ablation), device implantations (pacemakers, ICDs, CRT/CRTD), peripheral vascular interventions, and congenital heart disease treatments. The portfolio also includes advanced diagnostic imaging (320-row coronary CT, cardiac catheterization, echocardiography, MRI, RI scintigraphy), a cardiac rehabilitation program, a preventive health checkup service (Premium Heart & Brain Dock), in-hospital day care, and a remote monitoring system for cardiac devices. The hospital operates as a high-volume center with multidisciplinary "Heart Team" collaboration between cardiovascular surgery and cardiology, supported by hybrid operating rooms, heliport, and emergency doctor car services.
Differentiator
Problem solved
Functional benefit
Brands
- ハート号 (Heart-Go Doctor Car): The hospital's dedicated emergency response doctor car service for cardiovascular emergencies
Products and services
- MICS Minimally Invasive Cardiac Surgery (低侵襲心臓手術) Minimally invasive cardiac surgery using small incisions for valvular disease treatment, reducing patient recovery time compared to traditional open-heart surgery. Indicated for patients with mitral and other valve disease seeking faster recovery.
- TAVI Transcatheter Aortic Valve Implantation (経カテーテル的大動脈弁置換術) Transcatheter aortic valve implantation for aortic valve stenosis, enabling valve replacement without open-heart surgery. Provided to patients with aortic stenosis, including dialysis patients. Hospital is a certified TAVI specialist facility.
- MitraClip / M-TEER Percutaneous Mitral Valve Repair (経皮的僧帽弁接合不全修復術) Transcatheter mitral valve repair using the MitraClip system for mitral regurgitation, a catheter-based alternative to open surgery. Hospital is a designated MitraClip Training Center. Indicated for patients with mitral regurgitation.
- TriClip / T-TEER Percutaneous Tricuspid Valve Repair (経皮的三尖弁接合不全修復術) Transcatheter tricuspid valve repair using the TriClip system for tricuspid regurgitation, newly introduced at the hospital as of April 2026. Indicated for patients with tricuspid regurgitation.
- Aortic Aneurysm Stent Graft and Artificial Vessel Replacement (大動脈瘤ステントグラフト留置術・人工血管置換術) Endovascular stent graft placement and artificial blood vessel replacement for aortic aneurysms, covering both thoracic and abdominal aorta. Provided to patients with aortic aneurysm and acute aortic emergencies.
- CABG Coronary Artery Bypass Grafting (冠動脈バイパス手術) Coronary artery bypass grafting including off-pump (beating heart) bypass surgery for ischemic heart disease. Indicated for patients with coronary artery disease requiring surgical revascularization.
- PCI Percutaneous Coronary Intervention (冠動脈ステント治療) Percutaneous coronary intervention with stent placement for coronary artery disease, including drug-eluting stents and adjunct therapies such as excimer laser and Rotablator for complex lesions.
- Catheter Ablation (カテーテルアブレーション) Catheter ablation for cardiac arrhythmias including atrial fibrillation, using advanced mapping and ablation systems. Indicated for patients with refractory arrhythmia.
- Cardiac Pacemaker, ICD, CRT/CRTD Implantation (心臓ペースメーカ・ICD・CRT/CRTD) Implantation of cardiac pacemaker, implantable cardioverter-defibrillator (ICD), and cardiac resynchronization therapy (CRT/CRTD) devices for bradycardia, arrhythmia, and heart failure management, including leadless pacemakers.
- Remote Cardiac Device Monitoring System (遠隔モニタリングシステム) Remote monitoring system for implanted cardiac devices (pacemakers, ICDs) allowing continuous data transmission and remote follow-up of patients after device implantation.
- Implantable Ventricular Assist Device Therapy (植込型補助人工心臓 VAD) Ventricular assist device (VAD) implantation for severe heart failure patients, with the hospital designated as an authorized VAD management facility. Indicated for end-stage heart failure patients.
- Peripheral Vascular Stent Treatment (末梢血管ステント治療) Peripheral vascular stent treatment for peripheral artery disease, including lower extremity, dialysis shunt, carotid, subclavian, and renal artery interventions.
- Congenital Heart Disease Treatment (先天性心疾患治療) Surgical and catheter-based treatment for congenital heart diseases in adults and children, including patent foramen ovale (PFO) closure and atrial septal defect (ASD) closure. Migraine-treatment PFO closure offered as self-pay service.
- Same-day / One-night Cardiac Catheterization Examination (日帰り/1泊心臓カテーテル検査) Diagnostic cardiac catheterization examination offered as same-day or one-night-stay procedure, reducing unnecessary hospitalization for patients requiring diagnostic assessment.
- 320-Row Coronary CT Scan (320列冠動脈CT検査) 320-row coronary CT angiography for non-invasive imaging of coronary arteries, using the Aquilion Prime SP CT scanner system for high-sensitivity, rapid imaging.
- Premium Cardiac and Brain Dock (プレミアム心臓・脳ドック) Self-pay preventive health screening package combining advanced cardiac and neurological examinations for comprehensive preventive health assessment. Indicated for health-conscious individuals seeking early disease detection.
- Cardiac Rehabilitation Program (心臓リハビリテーション) Supervised exercise training and education program for recovery from cardiac events and surgeries, and for secondary prevention of cardiovascular disease.
- Emergency Doctor Car Service (ドクターカー / Heart-Go) Emergency response vehicle with doctor and nurse dispatched to provide in-transit life-saving treatment. Equipped with ECMO and advanced life support equipment for cardiac emergency transport from referring hospitals.
- Online Second Opinion Consultation (セカンドオピニオン) Online and telephone second opinion consultation service providing expert cardiac opinion to patients remotely seeking alternative medical advice.
Quantifiable outcome
- MitraClip 30-day mortality: 0%, surgical conversion rate: 0%
- +3 more outcomes
Companies that use Juzenkai Medical Association
Customer profileNamed customers2 records
Segments1 record
Ideal customer profiles3 records
Juzenkai Medical Association technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature12 records
Juzenkai Medical Association partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Okayama Emergency Medical Network (岡山救急ワイヤレッドネットワーク)coreRegional medical coordination corporation (地域医療連携推進法人) established April 2021 as Okayama Prefecture's first such entity. Partners: Okayama Eastern Neurosurgery Hospital (瀧澤貴昭理事长) and Sakakibara Heart Center. Provides 'no-refusal' emergency care for cardiac disease, aortic disease, and stroke across the region.
- Osaka University (大阪大学) - Joint Cardiovascular ConferencecoreAnnual joint cardiovascular conference held alternately at Osaka University and Sakakibara Heart Center. Includes case discussions, lectures, and academic exchange between faculties. 5th conference held in October 2017.
Scale indicators18 records
Recent moves8 records
Expansion highlights6 records
Juzenkai Medical Association competitors and assessment
Company assessmentBroad incumbents
- Kameda Medical Center: Large integrated medical center in Kamogawa with strong cardiovascular surgery and interventional cardiology programs. Comparable as a regional high-acuity cardiac provider offering a similar breadth of structural heart and catheter-based therapies.
- Keio University Hospital: Major Tokyo academic hospital with leading cardiology and cardiac surgery programs including structural heart interventions. Comparable as a high-acuity Japanese cardiac provider with research and training depth.
- Toranomon Hospital: Large Tokyo general hospital with a renowned cardiovascular center performing high-volume cardiac surgery and catheter-based interventions. Comparable as a high-volume cardiac provider with Heart Team approach and structural heart capabilities.
- Cleveland Clinic (Heart, Vascular & Thoracic Institute): Globally renowned U.S. cardiovascular specialty center and a benchmark for structural heart, TAVI, and MitraClip volume. Comparable to Sakakibara as a leading specialty heart institute with MitraClip Training Center heritage and high transcatheter procedure volumes.
- Juntendo University Hospital: Major Tokyo academic medical center with strong cardiology and cardiac surgery programs. Comparable as a high-volume cardiac care provider with structural heart and advanced intervention capabilities, though broader in scope than Sakakibara's cardiac specialty focus.
- St. Luke's International Hospital: Large Tokyo-based hospital with a strong cardiovascular center and Heart Team approach. Comparable as a high-volume cardiac provider offering structural heart, catheter-based, and surgical therapies in a Japanese urban setting.
- Osaka University Hospital: Major academic medical center in Osaka with extensive cardiovascular programs and an established joint academic conference partnership with Sakakibara. Comparable as a high-acuity cardiac provider and academic exchange partner.
Direct peers
- Kokura Memorial Hospital: Cardiovascular specialty hospital in Kitakyushu, Japan, offering high-volume cardiac surgery, catheter intervention, and structural heart procedures. Highly comparable to Sakakibara as one of Japan's leading regional cardiac specialty hospitals with similar transcatheter and surgical capabilities.
- Saiseikai Kumamoto Hospital: Regional cardiac specialty hospital in Kumamoto performing high volumes of cardiac surgery and catheter interventions. Comparable to Sakakibara as a regional Japanese cardiac specialty center with similar procedural mix and emergency cardiac capability.
- National Cerebral and Cardiovascular Center: Japan's national specialty hospital for cardiovascular and cerebral disease in Osaka, focused on advanced cardiac surgery, structural heart, and research. Comparable to Sakakibara as a high-acuity specialty center with deep transcatheter and surgical capabilities.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Juzenkai Medical Association social profiles
Digital presenceJuzenkai Medical Association financial estimates
Financial estimateRevenue estimate
Valuation estimate
Juzenkai Medical Association leadership team
Management profileNumber of profiles
Profiles11 records
Juzenkai Medical Association funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Juzenkai Medical Association M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Juzenkai Medical Association
What does Juzenkai Medical Association do?
Juzenkai Medical Association operates the Sakakibara Heart Institute of Okayama (心臓病センター榊原病院), a cardiovascular specialty hospital established in 1932. It delivers comprehensive cardiac care including open-heart and minimally invasive cardiac surgery (MICS, CABG, aortic surgery, VAD), catheter-based interventions (TAVI, MitraClip/M-TEER, TriClip/T-TEER, PCI, catheter ablation), cardiac device implantation (pacemaker, ICD, CRT/CRTD, leadless pacemaker), peripheral vascular stenting, advanced diagnostic imaging (320-row CT, RI scintigraphy, cardiac catheterization), cardiac rehabilitation, and a self-pay preventive Premium Heart and Brain Dock.
Is Juzenkai Medical Association a public or private company?
Juzenkai Medical Association is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Juzenkai Medical Association founded?
Juzenkai Medical Association was founded in 1932. It employs 1 to 10 people.
Where is Juzenkai Medical Association based?
Juzenkai Medical Association is headquartered in Okayama, Japan, in the Asia region.
How does Juzenkai Medical Association make money?
Two revenue lines are on record. Public Health Insurance Medical Services are the primary driver. The others are premium Health Checkup Services (Self-Pay).
Who are Juzenkai Medical Association's main competitors?
Broad incumbents on record are Kameda Medical Center, Keio University Hospital, Toranomon Hospital, Cleveland Clinic (Heart, Vascular & Thoracic Institute), Juntendo University Hospital, St. Luke's International Hospital and Osaka University Hospital. Direct peers are Kokura Memorial Hospital, Saiseikai Kumamoto Hospital and National Cerebral and Cardiovascular Center.
Does Juzenkai Medical Association have an API?
No public API is recorded for Juzenkai Medical Association.
What industry is Juzenkai Medical Association in?
Juzenkai Medical Association's product category is Cardiovascular Specialty Hospital Services. Its primary akta.pro industry code is HLAFAHAA, Cardiac & Cardiothoracic Specialty Hospitals, with a secondary code of HLAKABAB, Interventional Cardiology (PCI/Structural Heart). Its NAICS code is 622310 and its SIC code is 8060.